Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

FedEx, Lyft Rise Premarket, Nike Falls

Published 03/19/2021, 08:01 AM
Updated 03/19/2021, 08:01 AM
© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Friday, March 19th. Please refresh for updates.

  • FedEx (NYSE:FDX) stock rose 5.1% after the delivery firm said its quarterly profit jumped more than expected on higher prices and surging volume from pandemic-fueled e-commerce deliveries during the holiday shipping season.

  • Nike (NYSE:NKE) stock fell 2.2% after quarterly sales from the world’s largest shoe maker missed estimates due to shipping issues and a pandemic-related slump at brick-and-mortar stores, while its full-year revenue forecast also disappointed.

  • Tesla (NASDAQ:TSLA) stock fell 0.7% after Bloomberg reported that the Chinese military has banned the company's cars from military complexes and housing compounds because of concerns about sensitive data being collected by cameras built into the vehicles.
  • Amazon (NASDAQ:AMZN) stock rose 0.8% after the company signed a deal with the NFL, becoming the exclusive partner for the league's "Thursday Night Football" games, the first time a streaming service will carry an exclusive package of games.

  • Lyft (NASDAQ:LYFT) stock rose 0.2% after the ride-hailing company reported that last week was its biggest since March 2020, with ride volume reaching a record for the year. 

  • Ford (NYSE:F) stock rose 3.8% after the automaker said it will for now assemble its flagship, highly profitable F-150 pickup trucks and Edge SUVs in North America without certain parts and idle two assembly plants due to the global semiconductor chip shortage.

  • AstraZeneca (NASDAQ:AZN) ADR rose 0.4% after both European and British medical regulators recommended that its Covid-19 vaccine, developed with Oxford University, should continue to be rolled out despite reports of blood clots.

  • Sarepta Therapeutics (NASDAQ:SRPT) stock rose 3.4% after the biopharmaceutical company released encouraging trial results for its muscular dystrophy treatment. 

  • Skillz Platform (NYSE:SKLZ) stock fell 8% after the mobile gaming company announced a 32 million share public offering, priced at $24 per share.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

 

Latest comments

The market today is quite encouraging. Hope all the main index continue to drop in next few more days.
suddenly everyone knows more then the market 🙄
how do you all get paid to write this garbage?
lyft rise? .18% lol. I own the stock so I'm happy for any pump. But come on, it hasn't even been up 2% ALL premarket.
No.  Nike's slump is not because of pandemy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.